This company has been marked as potentially delisted and may not be actively trading. 2seventy bio (TSVT) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock TSVT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period 2seventy bio, Inc. (NASDAQ:TSVT) Shares Acquired by Western Standard LLCMay 22, 2025 | marketbeat.comStonepine Capital Management LLC Has $882,000 Stock Position in 2seventy bio, Inc. (NASDAQ:TSVT)May 20, 2025 | marketbeat.comDimensional Fund Advisors LP Has $1.40 Million Holdings in 2seventy bio, Inc. (NASDAQ:TSVT)May 18, 2025 | marketbeat.comMadison Avenue Partners LP Sells 1,983,327 Shares of 2seventy bio, Inc. (NASDAQ:TSVT)May 16, 2025 | marketbeat.com2seventy bio (NASDAQ:TSVT) Given "Sell (D-)" Rating at Weiss RatingsMay 12, 2025 | marketbeat.comEngine Capital Management LP Sells 585,977 Shares of 2seventy bio, Inc. (NASDAQ:TSVT)May 11, 2025 | marketbeat.comDAFNA Capital Management LLC Sells 200,777 Shares of 2seventy bio, Inc. (NASDAQ:TSVT)May 10, 2025 | marketbeat.com2seventy bio (TSVT) Projected to Post Quarterly Earnings on WednesdayMay 9, 2025 | marketbeat.com2seventy bio Reports First Quarter Financial Results and Provides Update on Proposed Acquisition by Bristol Myers SquibbMay 7, 2025 | businesswire.comSusquehanna Fundamental Investments LLC Makes New Investment in 2seventy bio, Inc. (NASDAQ:TSVT)May 7, 2025 | marketbeat.com2seventy bio, Inc. (NASDAQ:TSVT) Shares Sold by Marshall Wace LLPMay 3, 2025 | marketbeat.com2seventy bio, Inc. (NASDAQ:TSVT) Given Average Recommendation of "Hold" by BrokeragesMay 1, 2025 | marketbeat.com2seventy bio (NASDAQ:TSVT) Earns Sell (E+) Rating from Weiss RatingsApril 27, 2025 | marketbeat.com2seventy bio, Inc. (NASDAQ:TSVT) Sees Significant Drop in Short InterestApril 21, 2025 | marketbeat.com2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVTApril 16, 2025 | businesswire.comWeiss Ratings Reiterates Sell (D-) Rating for 2seventy bio (NASDAQ:TSVT)April 10, 2025 | marketbeat.com2seventy bio, Inc. (NASDAQ:TSVT) Given Average Rating of "Hold" by BrokeragesApril 5, 2025 | marketbeat.com2seventy bio, Inc. (NASDAQ:TSVT) Short Interest UpdateMarch 31, 2025 | marketbeat.com2seventy Bio reports Q4 EPS (37c) vs ($1.11) last yearMarch 27, 2025 | markets.businessinsider.com2seventy bio (NASDAQ:TSVT) Announces Earnings Results, Misses Expectations By $0.11 EPSMarch 26, 2025 | marketbeat.com2seventy bio Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 25, 2025 | businesswire.com2seventy bio's (TSVT) Sell (E+) Rating Reiterated at Weiss RatingsMarch 24, 2025 | marketbeat.com2seventy bio, Inc. (NASDAQ:TSVT) COO Jessica Snow Sells 2,298 SharesMarch 20, 2025 | marketbeat.comInsider Selling: 2seventy bio, Inc. (NASDAQ:TSVT) CFO Sells 2,592 Shares of StockMarch 20, 2025 | marketbeat.comWilliam D. Baird III Sells 5,092 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) StockMarch 20, 2025 | marketbeat.comJessica Snow Sells 2,298 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) StockMarch 20, 2025 | insidertrades.comMonimus Capital Management LP Invests $775,000 in 2seventy bio, Inc. (NASDAQ:TSVT)March 16, 2025 | marketbeat.comMorgan Stanley Lowers 2seventy bio (NASDAQ:TSVT) Price Target to $5.00March 15, 2025 | marketbeat.comInsider Selling: 2seventy bio, Inc. (NASDAQ:TSVT) Major Shareholder Sells 5,142,111 Shares of StockMarch 14, 2025 | marketbeat.com2seventy Bio price target lowered to $5 from $6 at Morgan StanleyMarch 14, 2025 | markets.businessinsider.com2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVTMarch 14, 2025 | businesswire.com2seventy bio, Inc. (NASDAQ:TSVT) Major Shareholder Sells $25,350,607.23 in StockMarch 14, 2025 | insidertrades.com2seventy bio (NASDAQ:TSVT) Downgraded to Hold Rating by Leerink PartnrsMarch 14, 2025 | marketbeat.comBiotech Stock Roundup: TSVT Up on BMY Deal, PTGX Up on Data & MoreMarch 13, 2025 | msn.com$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of 2seventy bio, Inc. - TSVTMarch 12, 2025 | prnewswire.com2seventy bio (NASDAQ:TSVT) Given Market Perform Rating at Leerink PartnersMarch 12, 2025 | marketbeat.comShareholder Alert: The Ademi Firm investigates whether 2seventy bio, Inc. is obtaining a Fair Price for its Public ShareholdersMarch 11, 2025 | businesswire.comTSVT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 2seventy bio, Inc. Is Fair to ShareholdersMarch 11, 2025 | tmcnet.com2seventy Bio to be acquired by Bristol Myers for $5.00 per share in cashMarch 11, 2025 | markets.businessinsider.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc.March 11, 2025 | prnewswire.com1,254,827 Shares in 2seventy bio, Inc. (NASDAQ:TSVT) Acquired by Regeneron Pharmaceuticals Inc.March 11, 2025 | marketbeat.com2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers SquibbMarch 10, 2025 | businesswire.com2seventy bio, Inc. (NASDAQ:TSVT) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMarch 10, 2025 | marketbeat.com2seventy bio (NASDAQ:TSVT) Receives Sell (D-) Rating from Weiss RatingsMarch 8, 2025 | marketbeat.com2seventy bio to Participate in the 2025 TD Cowen Healthcare ConferenceFebruary 25, 2025 | finance.yahoo.com2seventy bio to Participate in the 2025 TD Cowen Healthcare ConferenceFebruary 25, 2025 | businesswire.com2seventy bio (TSVT) Projected to Post Earnings on TuesdayFebruary 25, 2025 | marketbeat.comWeiss Ratings Reiterates "Sell (D-)" Rating for 2seventy bio (NASDAQ:TSVT)February 20, 2025 | marketbeat.com2seventy bio, Inc. (NASDAQ:TSVT) Given Average Rating of "Moderate Buy" by BrokeragesFebruary 13, 2025 | marketbeat.comCiti cuts 2Seventy Bio stock target to $9, maintains Buy ratingFebruary 6, 2025 | msn.com Get 2seventy bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TSVT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TSVT Media Mentions By Week TSVT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TSVT News Sentiment▼0.000.96▲Average Medical News Sentiment TSVT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TSVT Articles This Week▼02▲TSVT Articles Average Week Get the Latest News and Ratings for TSVT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for 2seventy bio and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Sionna Therapeutics News Today atai Life Sciences News Today CorMedix News Today Stoke Therapeutics News Today Nuvation Bio News Today Spyre Therapeutics News Today Praxis Precision Medicines News Today Cronos Group News Today Verve Therapeutics News Today Mineralys Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TSVT) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 2seventy bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 2seventy bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TSVT Stock Alerts